GI side effects: nausea, vomiting, and diarrhea are common early on
Patients in the United States are suing Eli Lilly because they say they were not told that Mounjaro increases the risks of gastroparesis, sudden vision loss, pancreatitis, and other serious medical conditions
Understanding GHK-Cu's tolerability requires being honest about the boundaries of the evidence
The main concerns with GLP-1 agonist drugs include: GI side effects (nausea, diarrhea, vomiting, constipation, abdominal pain) High out-of-pocket cost for those who do not quality under insurance Risk of inadequate nutrition (reduced intake + insufficient nutrition counseling) Significant loss of muscle mass & bone density High discontinuation rates (with lost weight regained) Limited public & clinician knowledge on importance/implementation of nutrition and lifestyle changes Side Effects and Costs of GLP-1 Medications The use of GLP-1 drugs has been associated with numerous side effects, ranging from mild to severe
Major clinical studies involving Semaglutide, Tirzepatide, and Liraglutide primarily enrolled patients who met established BMI thresholds